MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
TWST Twist Bioscience
- 47.940
- +4.320+9.90%
Close Dec 20 16:00 ET
- 49.000
- +1.060+2.21%
Post 20:01 ET
2.85BMarket Cap-13.32P/E (TTM)
48.000High42.890Low2.28MVolume43.290Open43.620Pre Close108.04MTurnover3.90%Turnover RatioLossP/E (Static)59.36MShares60.90052wk High6.02P/B2.80BFloat Cap27.41052wk Low--Dividend TTM58.36MShs Float214.070Historical High--Div YieldTTM11.72%Amplitude11.460Historical Low47.428Avg Price1Lot Size
Twist Bioscience Key Stats
Quarterly+Annual
YOY
| (FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 55.01%-64.09M | 26.00%-15.32M | 72.76%-6.38M | 56.14%-19.42M | 57.51%-22.97M | -14.54%-142.47M | -1,534.10%-20.7M | 31.39%-23.41M | -4.60%-44.29M | -15.90%-54.07M |
| Net income from continuing operations | -2.01%-208.73M | 25.06%-34.66M | -49.09%-85.57M | 23.10%-45.49M | -2.83%-43.01M | 6.08%-204.62M | 9.53%-46.24M | 5.16%-57.4M | 2.49%-59.16M | 8.21%-41.82M |
| Depreciation and amortization | 7.24%31.43M | -21.69%6.66M | -2.23%8.3M | 18.16%8.3M | 54.40%8.17M | 77.49%29.31M | 71.65%8.5M | 91.04%8.49M | 77.12%7.03M | 68.00%5.29M |
| Other non cash items | 160.06%1.93M | -12.69%1.47M | 54.80%-334K | 184.47%484K | 108.68%312K | -144.33%-3.22M | -90.50%1.69M | 77.23%-739K | 89.73%-573K | -117.55%-3.59M |
| Change In working capital | 1,627.35%15.41M | -358.50%-1.14M | 4.55%12.56M | 287.27%3.46M | 104.58%532K | 81.16%-1.01M | -82.53%441K | 141.12%12.02M | 20.36%-1.85M | -10.17%-11.62M |
| -Change in receivables | 295.46%8.44M | -63.02%-2.95M | -27.88%4M | 83.38%-657K | 296.63%8.06M | 55.10%-4.32M | -373.72%-1.81M | 186.07%5.54M | -117.98%-3.95M | -101.67%-4.1M |
| -Change in inventory | 10.33%7.99M | 2.77%4.41M | -46.81%1.89M | -89.60%486K | 122.74%1.2M | 196.05%7.24M | 15.89%4.29M | 129.35%3.56M | 207.45%4.68M | 37.40%-5.28M |
| -Change in prepaid assets | 109.17%382K | 125.41%567K | 168.31%235K | 268.12%696K | 5.18%-1.12M | -63.31%-4.17M | -1,305.95%-2.23M | 74.12%-344K | 68.54%-414K | -1,193.41%-1.18M |
| -Change in payables and accrued expense | 147.13%485K | -249.32%-2.65M | 356.13%5.54M | 270.58%3.98M | -278.14%-6.38M | -107.09%-1.03M | -77.55%1.78M | -80.16%1.22M | -163.82%-2.33M | 46.98%-1.69M |
| -Change in other current assets | -68.68%431K | -112.58%-41K | 204.49%163K | -98.73%9K | -39.88%300K | -81.08%1.38M | -26.58%326K | -105.28%-156K | 10.12%707K | -84.56%499K |
| -Change in other current liabilities | -2,045.37%-2.32M | 75.46%-468K | -66.68%734K | -99.06%-1.06M | -1,312.70%-1.53M | 98.55%-108K | 81.62%-1.91M | 3.82%2.2M | -161.20%-530K | 470.59%126K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 55.01%-64.09M | 26.00%-15.32M | 72.76%-6.38M | 56.14%-19.42M | 57.51%-22.97M | -14.54%-142.47M | -1,534.10%-20.7M | 31.39%-23.41M | -4.60%-44.29M | -15.90%-54.07M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -106.07%-3.07M | 42.81%-1.29M | -103.81%-711K | -112.73%-5.24M | 159.75%4.17M | 121.73%50.61M | -180.74%-2.25M | 348.47%18.67M | 409.61%41.16M | 96.92%-6.97M |
| Net PPE purchase and sale | 81.73%-5.08M | 16.34%-2M | 78.60%-965K | 93.34%-603K | 87.26%-1.51M | 72.73%-27.78M | 85.46%-2.39M | 88.91%-4.51M | 71.68%-9.05M | 7.50%-11.82M |
| Net business purchase and sale | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net investment purchase and sale | -97.44%2.01M | 391.10%717K | -98.90%254K | -109.23%-4.64M | 16.86%5.67M | 166.91%78.39M | -99.42%146K | -48.27%23.18M | 168.86%50.21M | 102.36%4.85M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -106.07%-3.07M | 42.81%-1.29M | -103.81%-711K | -112.73%-5.24M | 159.75%4.17M | 121.73%50.61M | -180.74%-2.25M | 348.47%18.67M | 409.61%41.16M | 96.92%-6.97M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 656.31%6.89M | 720.59%3.63M | 539.94%2.91M | 19.87%1.83M | -272.91%-1.47M | -99.66%911K | -64.35%442K | 49.58%-661K | -99.44%1.53M | 60.93%-395K |
| Net issuance payments of debt | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net common stock issuance | 9.76%-3.98M | 99.29%-8K | 99.31%-7K | -21.71%-1.54M | -142.64%-2.42M | -101.68%-4.41M | 30.50%-1.13M | 51.11%-1.01M | -100.47%-1.26M | 60.95%-999K |
| Proceeds from stock option exercised by employees | 104.38%10.87M | 131.23%3.64M | 725.78%2.92M | 20.70%3.36M | 57.45%951K | -46.97%5.32M | -45.15%1.57M | -53.74%353K | -15.29%2.79M | -80.55%604K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 656.31%6.89M | 720.59%3.63M | 539.94%2.91M | 19.87%1.83M | -272.91%-1.47M | -99.66%911K | -64.35%442K | 49.58%-661K | -99.44%1.53M | 60.93%-395K |
| Net cash flow | ||||||||||
| Beginning cash position | -23.93%289.28M | -22.38%242.04M | -22.47%246.22M | -15.66%269.12M | -23.93%289.28M | -18.64%380.26M | -17.46%311.84M | -22.39%317.56M | 65.16%319.09M | -18.64%380.26M |
| Current changes in cash | 33.73%-60.28M | 42.34%-12.98M | 22.62%-4.18M | -1,324.52%-22.84M | 66.99%-20.28M | -4.81%-90.95M | -916.73%-22.51M | 82.72%-5.4M | -100.74%-1.6M | 77.60%-61.44M |
| Effect of exchange rate changes | 566.67%126K | 252.08%73K | 100.63%2K | -189.04%-65K | -56.72%116K | 91.54%-27K | 84.91%-48K | -204.76%-320K | 247.62%73K | 222.89%268K |
| End cash Position | -20.79%229.13M | -20.79%229.13M | -22.38%242.04M | -22.47%246.22M | -15.66%269.12M | -23.93%289.28M | -23.93%289.28M | -17.46%311.84M | -22.39%317.56M | 65.16%319.09M |
| Free cash flow | 59.37%-69.17M | 25.00%-17.32M | 73.70%-7.34M | 62.46%-20.03M | 62.85%-24.48M | 24.75%-170.25M | -30.28%-23.1M | 62.66%-27.92M | 28.22%-53.34M | -10.87%-65.89M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.